The results also showed that the expression inhibition of VEGFR2 partially reversed the impact of ECM1 overexpression on PS VII's intervention on ovarian cancer cell proliferation, angiogenesis, glycolysis, and other functions (Supplementary Figure 2B-F). The gene discussed is ECM1; the disease is ovarian carcinoma.